Harel Insurance Investments & Financial Services Ltd. increased its stake in shares of Mazor Robotics Ltd. (NASDAQ:MZOR) by 5.4% during the second quarter, Holdings Channel reports. The institutional investor owned 180,180 shares of the medical instruments supplier’s stock after buying an additional 9,276 shares during the period. Harel Insurance Investments & Financial Services Ltd.’s holdings in Mazor Robotics were worth $6,231,000 at the end of the most recent reporting period.

Several other hedge funds and other institutional investors also recently bought and sold shares of the stock. JPMorgan Chase & Co. boosted its position in Mazor Robotics by 398.5% in the first quarter. JPMorgan Chase & Co. now owns 6,979 shares of the medical instruments supplier’s stock valued at $208,000 after buying an additional 5,579 shares during the last quarter. Eagle Asset Management Inc. purchased a new position in Mazor Robotics during the first quarter valued at $225,000. Point72 Asset Management L.P. purchased a new position in Mazor Robotics during the first quarter valued at $709,000. Menta Capital LLC purchased a new position in Mazor Robotics during the first quarter valued at $815,000. Finally, Messner & Smith Theme Value Investment Management Ltd. CA purchased a new position in Mazor Robotics during the first quarter valued at $872,000. 28.37% of the stock is currently owned by institutional investors.

Mazor Robotics Ltd. (MZOR) opened at 37.24 on Thursday. Mazor Robotics Ltd. has a 12-month low of $20.19 and a 12-month high of $45.64. The stock’s 50 day moving average is $38.01 and its 200 day moving average is $32.16. The stock’s market capitalization is $897.97 million.

Mazor Robotics (NASDAQ:MZOR) last issued its quarterly earnings data on Tuesday, August 1st. The medical instruments supplier reported ($0.16) EPS for the quarter, topping analysts’ consensus estimates of ($0.25) by $0.09. Mazor Robotics had a negative net margin of 37.66% and a negative return on equity of 28.51%. The business had revenue of $15.46 million for the quarter, compared to analyst estimates of $15.38 million. During the same period last year, the business posted ($0.09) earnings per share. The firm’s quarterly revenue was up 86.7% on a year-over-year basis. Analysts forecast that Mazor Robotics Ltd. will post ($0.82) EPS for the current year.

WARNING: “Harel Insurance Investments & Financial Services Ltd. Raises Position in Mazor Robotics Ltd. (NASDAQ:MZOR)” was first published by Watch List News and is owned by of Watch List News. If you are accessing this piece on another domain, it was stolen and reposted in violation of United States & international copyright & trademark laws. The original version of this piece can be accessed at https://www.watchlistnews.com/harel-insurance-investments-financial-services-ltd-raises-position-in-mazor-robotics-ltd-nasdaqmzor/1470364.html.

MZOR has been the topic of several research analyst reports. Needham & Company LLC reiterated a “hold” rating on shares of Mazor Robotics in a research report on Wednesday, May 24th. Standpoint Research cut shares of Mazor Robotics from a “buy” rating to a “reduce” rating and lowered their price objective for the stock from $32.98 to $28.00 in a research report on Wednesday, April 19th. They noted that the move was a valuation call. Zacks Investment Research upgraded shares of Mazor Robotics from a “sell” rating to a “hold” rating in a research report on Saturday, April 22nd. Wells Fargo & Company cut shares of Mazor Robotics from an “outperform” rating to a “market perform” rating in a report on Thursday, May 11th. Finally, JMP Securities cut shares of Mazor Robotics from an “outperform” rating to a “market perform” rating in a report on Friday, May 12th. They noted that the move was a valuation call. Two investment analysts have rated the stock with a sell rating, seven have given a hold rating and one has given a buy rating to the stock. The stock has a consensus rating of “Hold” and a consensus price target of $33.50.

About Mazor Robotics

Mazor Robotics Ltd is an Israel-based medical device company that develops and markets surgical guidance systems and complementary products. It develops computerized and imaging-based systems in the field of spine surgery. Its products include: Renaissance Surgical Guidance System, which enables surgeons to advance from freehand surgical procedures to guided procedures, as well as Food and Drug Administration (FDA)-cleared and European Conformity (CE)-marked Renaissance System, used in spine surgeries, whether open or minimally invasive, for a number of clinical indications.

Want to see what other hedge funds are holding MZOR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Mazor Robotics Ltd. (NASDAQ:MZOR).

Institutional Ownership by Quarter for Mazor Robotics (NASDAQ:MZOR)

Receive News & Ratings for Mazor Robotics Ltd. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Mazor Robotics Ltd. and related companies with Analyst Ratings Network's FREE daily email newsletter.